---
figid: PMC9204157__fphar-13-918771-g006
figtitle: Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary
  Fibrosis
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Severe acute respiratory syndrome coronavirus 2
pmcid: PMC9204157
filename: fphar-13-918771-g006.jpg
figlink: /pmc/articles/PMC9204157/figure/F6/
number: F6
caption: The roles of the JAK/STAT pathway, PI3K/Akt/mTOR pathway, MAPK pathway, and
  Hippo-YAP/TAZ pathway in IPF. (A) After interleukins and growth factors bind to
  the corresponding receptors, they can activate the JAKs coupled to the receptors,
  and then JAKs can phosphorylate STAT. Homodimerized STAT enters the nucleus and
  affects gene transcription. (B) Growth factors and cytokines can activate PI3K by
  binding to receptor-type tyrosine kinases, and then PI3K catalyzes the phosphorylation
  of PIP2 to PIP3. PIP3 can activate Akt and its downstream mTOR complex (mTORC).
  PTEN is a negative regulator of the PI3K/Akt/mTOR pathway. TGF-β and Notch are positive
  regulators of Akt. (C) The MAPK pathway consists of three downstream cascades, the
  JNK, p38, and ERK pathways. JNK and p38 signaling are activated through a pattern
  of MAP3K-MAP2K-MAPK signaling cascades, while ERK is activated through the MAP3K-Ras-Raf-MEK-ERK
  cascade. MK2 is a downstream signaling molecule of p38. Growth factors can activate
  ERK5, and ERK5 and p90RSK can acetylate Smad, thereby promoting the TGF-β/Smad pathway.
  (D) The Hippo-YAP/TAZ pathway is involved in pulmonary fibrosis through the integrin
  pathway, G protein-coupled receptor pathway, and mechanotransduction pathway. ECM
  force initiates the Hippo-YAP/TAZ pathway with activation of FAK and Rho/ROCK. FAK
  and Rho/ROCK relieve the inhibition of the transcription factor YAP/TAZ by large
  tumor suppressor kinase 1 and 2 (LAST1/2) by promoting the growth, stability, and
  contractibility of F-actin. Different GPCR signaling pathways regulate LAST1/2 activity
  through the Rho/ROCK/F-actin pathway.
papertitle: Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary
  Fibrosis.
reftext: Hongbo Ma, et al. Front Pharmacol. 2022;13:918771.
year: '2022'
doi: 10.3389/fphar.2022.918771
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: cytokine | growth factor | signaling pathway | clinical trials | idiopathic
  pulmonary fibrosis | emerging pharmacotherapy
automl_pathway: 0.9387334
figid_alias: PMC9204157__F6
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC9204157__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9204157__fphar-13-918771-g006.html
  '@type': Dataset
  description: The roles of the JAK/STAT pathway, PI3K/Akt/mTOR pathway, MAPK pathway,
    and Hippo-YAP/TAZ pathway in IPF. (A) After interleukins and growth factors bind
    to the corresponding receptors, they can activate the JAKs coupled to the receptors,
    and then JAKs can phosphorylate STAT. Homodimerized STAT enters the nucleus and
    affects gene transcription. (B) Growth factors and cytokines can activate PI3K
    by binding to receptor-type tyrosine kinases, and then PI3K catalyzes the phosphorylation
    of PIP2 to PIP3. PIP3 can activate Akt and its downstream mTOR complex (mTORC).
    PTEN is a negative regulator of the PI3K/Akt/mTOR pathway. TGF-β and Notch are
    positive regulators of Akt. (C) The MAPK pathway consists of three downstream
    cascades, the JNK, p38, and ERK pathways. JNK and p38 signaling are activated
    through a pattern of MAP3K-MAP2K-MAPK signaling cascades, while ERK is activated
    through the MAP3K-Ras-Raf-MEK-ERK cascade. MK2 is a downstream signaling molecule
    of p38. Growth factors can activate ERK5, and ERK5 and p90RSK can acetylate Smad,
    thereby promoting the TGF-β/Smad pathway. (D) The Hippo-YAP/TAZ pathway is involved
    in pulmonary fibrosis through the integrin pathway, G protein-coupled receptor
    pathway, and mechanotransduction pathway. ECM force initiates the Hippo-YAP/TAZ
    pathway with activation of FAK and Rho/ROCK. FAK and Rho/ROCK relieve the inhibition
    of the transcription factor YAP/TAZ by large tumor suppressor kinase 1 and 2 (LAST1/2)
    by promoting the growth, stability, and contractibility of F-actin. Different
    GPCR signaling pathways regulate LAST1/2 activity through the Rho/ROCK/F-actin
    pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Itk
  - Slc22a3
  - Akt1
  - Mtor
  - Pik3r1
  - Igf1r
  - Sema3b
  - Sema6b
  - Tgfb1
  - Ltbp1
  - Tsc2
  - Tsc1
  - Eif4ebp1
  - Nfkb1
  - Map3k7
  - Map2k4
  - ras
  - Hras
  - Kras
  - Rem1
  - Map2k3
  - Zhx2
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Mapk8
  - Kcna2
  - Mapkapk2
  - Map2k2
  - Mdk
  - Mapk3
  - Mapk1
  - Tafazzin
  - Wwtr1
  - Gpbar1
  - Gast
  - Gnas
  - Gna12
  - Ptk2
  - Gnaq
  - Gal
  - Ggta1
  - Gnao1
  - Rho
  - Rhod
  - Ea2
  - Yap1
  - Tbk1
  - Serpinb9d
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - ITK
  - SLC22A3
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IGF1R
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - SEMA3B
  - SEMA6A
  - TGFB1
  - TGFB2
  - TGFB3
  - TSC2
  - TSC1
  - CCL26
  - EIF4EBP1
  - RPTOR
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - NFKB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MAP3K7
  - MAP2K4
  - KRAS
  - HRAS
  - NRAS
  - MAP2K3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - KCNA2
  - MAPKAPK2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TAFAZZIN
  - WWTR1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - GAST
  - GALNS
  - PAGR1
  - PTK2
  - GNAQ
  - GAL
  - GALP
  - GNAO1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - ROCK1
  - ROCK2
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - YAP1
  - TBK1
  - AGTR2
  - PGR-AS1
  - Sptan1
  - Pik3cg
  - Notch1
  - Tas2r134
  - Rxfp2
---
